Asset Allocation

As of March 31, 2026.
Type % Net
Cash 12.11%
Stock 70.61%
Bond 17.06%
Convertible 0.00%
Preferred 0.06%
Other 0.16%
View Asset Allocation
Start Trial

Market Capitalization

Large --
Mid --
Small --
No Data Available
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 87.69%    % Emerging Markets: 0.09%    % Unidentified Markets: 12.22%

Americas 77.97%
77.86%
Canada 3.63%
United States 74.23%
0.11%
As of March 31, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 9.64%
United Kingdom 0.51%
9.13%
Austria 0.08%
Belgium 0.21%
Finland 0.28%
France 2.18%
Germany 2.11%
Ireland 0.82%
Italy 0.73%
Netherlands 1.62%
Portugal 0.05%
Spain 0.87%
Switzerland 0.14%
0.01%
Czech Republic 0.01%
0.00%
Greater Asia 0.17%
Japan 0.00%
0.02%
Australia 0.02%
0.15%
Singapore 0.15%
0.00%
Unidentified Region 12.22%

Bond Credit Quality Exposure

AAA 0.00%
AA 76.79%
A 0.00%
BBB 0.00%
BB 0.00%
B 0.00%
Below B 0.00%
    CCC 0.00%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.00%
Not Available 23.21%
Short Term 0.00%
As of March 31, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
18.42%
Materials
1.97%
Consumer Discretionary
6.85%
Financials
8.76%
Real Estate
0.84%
Sensitive
40.44%
Communication Services
7.29%
Energy
2.78%
Industrials
6.44%
Information Technology
23.93%
Defensive
11.67%
Consumer Staples
4.14%
Health Care
5.52%
Utilities
2.01%
Not Classified
0.21%
Non Classified Equity
0.21%
As of March 31, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of March 31, 2026
Type % Net
Government 100.0%
Corporate 0.00%
Securitized 0.00%
Municipal 0.00%
Other 0.00%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
60.59%
Less than 1 Year
60.59%
Intermediate
39.41%
1 to 3 Years
15.77%
3 to 5 Years
14.83%
5 to 10 Years
8.80%
Long Term
0.00%
10 to 20 Years
0.00%
20 to 30 Years
0.00%
Over 30 Years
0.00%
Other
0.00%
As of March 31, 2026
View Bond Maturity Exposure
Start Trial